Stock A234690 GREEN CROSS WELLBEING CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials GREEN CROSS WellBeing Corporation

Equities

A234690

KR7234690006

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 16/05/2024 am IST 		5-day change 1st Jan Change
9,760 KRW +0.83% Intraday chart for GREEN CROSS WellBeing Corporation -2.40% +20.05%
2022 GREEN CROSS WellBeing Corporation(KOSDAQ:A234690) dropped from S&P Global BMI Index CI
2020 GREEN CROSS WellBeing Corporation(KOSDAQ:A234690) added to S&P Global BMI Index CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 1,87,287 2,48,532 1,80,186 1,46,101 1,44,326
Enterprise Value (EV) 1 1,40,920 2,33,063 2,00,287 1,74,992 1,78,424
P/E ratio 26.3 x 163 x 26.9 x 18.3 x 21.4 x
Yield - - - - -
Capitalization / Revenue 2.8 x 3.29 x 1.98 x 1.33 x 1.2 x
EV / Revenue 2.11 x 3.08 x 2.2 x 1.59 x 1.48 x
EV / EBITDA 15.2 x 55.3 x 20.4 x 16 x 11.2 x
EV / FCF 42.2 x -11.7 x -4.55 x -28.9 x -30.8 x
FCF Yield 2.37% -8.55% -22% -3.46% -3.25%
Price to Book 2.25 x 2.99 x 2.04 x 1.52 x 1.44 x
Nbr of stocks (in thousands) 17,752 17,752 17,752 17,752 17,752
Reference price 2 10,550 14,000 10,150 8,230 8,130
Announcement Date 29/02/20 01/03/21 01/03/22 01/03/23 29/02/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales 1 66,938 75,603 90,968 1,09,729 1,20,535
EBITDA 1 9,257 4,212 9,841 10,918 15,876
EBIT 1 7,624 2,317 7,772 8,396 10,457
Operating Margin 11.39% 3.06% 8.54% 7.65% 8.68%
Earnings before Tax (EBT) 1 7,324 1,502 8,134 9,353 8,249
Net income 1 5,699 1,529 6,703 8,001 6,748
Net margin 8.51% 2.02% 7.37% 7.29% 5.6%
EPS 2 400.5 86.14 377.6 450.7 380.1
Free Cash Flow 1 3,339 -19,936 -44,025 -6,062 -5,795
FCF margin 4.99% -26.37% -48.4% -5.52% -4.81%
FCF Conversion (EBITDA) 36.07% - - - -
FCF Conversion (Net income) 58.59% - - - -
Dividend per Share - - - - -
Announcement Date 29/02/20 01/03/21 01/03/22 01/03/23 29/02/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 - - 20,101 28,891 34,098
Net Cash position 1 46,366 15,469 - - -
Leverage (Debt/EBITDA) - - 2.043 x 2.646 x 2.148 x
Free Cash Flow 1 3,339 -19,936 -44,025 -6,062 -5,795
ROE (net income / shareholders' equity) 10.2% 1.84% 7.82% 8.68% 6.87%
ROA (Net income/ Total Assets) 6.54% 1.31% 3.83% 3.63% 4.26%
Assets 1 87,128 1,16,841 1,74,968 2,20,518 1,58,379
Book Value Per Share 2 4,685 4,680 4,974 5,417 5,655
Cash Flow per Share 2 688.0 1,331 494.0 149.0 90.30
Capex 1 1,121 22,328 42,874 7,447 941
Capex / Sales 1.67% 29.53% 47.13% 6.79% 0.78%
Announcement Date 29/02/20 01/03/21 01/03/22 01/03/23 29/02/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Biopharmaceuticals

1st Jan change Capi.
GREEN CROSS WELLBEING CORPORATION Stock GREEN CROSS WellBeing Corporation
+20.05% 127M
CSL LIMITED Stock CSL Limited
+0.10% 91.42B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.16% 41.08B
BIOGEN INC. Stock Biogen Inc.
-10.97% 34.26B
UCB Stock UCB
+53.99% 25.27B
INCYTE CORPORATION Stock Incyte Corporation
-10.07% 12.81B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.25% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-44.00% 11.42B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.77% 9.16B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-6.90% 8.22B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A234690 Stock
  4. Financials GREEN CROSS WellBeing Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW